首页> 美国卫生研究院文献>CPT: Pharmacometrics Systems Pharmacology >A Survey of Software Tool Utilization and Capabilities for Quantitative Systems Pharmacology: What We Have and What We Need
【2h】

A Survey of Software Tool Utilization and Capabilities for Quantitative Systems Pharmacology: What We Have and What We Need

机译:定量系统药理学的软件工具利用率和能力概览:我们拥有和我们需要的

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Quantitative systems pharmacology (QSP) is a rapidly emerging discipline with application across a spectrum of challenges facing the pharmaceutical industry, including mechanistically informed prioritization of target pathways and combinations in discovery, target population, and dose expansion decisions early in clinical development, and analyses for regulatory authorities late in clinical development. QSP's development has influences from physiologic modeling, systems biology, physiologically‐based pharmacokinetic modeling, and pharmacometrics. Given a varied scientific heritage, a variety of tools to accomplish the demands of model development, application, and model‐based analysis of available data have been developed. We report the outcome from a community survey and resulting analysis of how modelers view the impact and growth of QSP, how they utilize existing tools, and capabilities they need improved to further accelerate their impact on drug development. These results serve as a benchmark and roadmap for advancements to the QSP tool set.
机译:定量系统药理学(QSP)是一门快速兴起的学科,其应用涉及制药行业面临的一系列挑战,包括在临床开发早期对发现,目标人群和剂量扩展决策中的目标途径和组合进行机械知情排序,并进行分析。监管部门在临床开发后期。 QSP的发展受到生理建模,系统生物学,基于生理的药代动力学建模和药理学的影响。鉴于各种科学遗产,已经开发出了多种工具来满足模型开发,应用和对可用数据进行基于模型的分析的需求。我们报告了社区调查的结果,并分析了建模人员如何看待QSP的影响和增长,他们如何利用现有工具以及需要改善的功能以进一步加速其对药物开发的影响。这些结果可作为QSP工具集改进的基准和路线图。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号